AL, B., M, M., A, V., NJ, A., TA, P., F, L., . . . M, S. (2021). Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum. JAMA neurology, 78(12), 1471. https://doi.org/10.1001/jamaneurol.2021.3671
Chicago Style (17th ed.) CitationAL, Benedet, et al. "Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum." JAMA Neurology 78, no. 12 (2021): 1471. https://doi.org/10.1001/jamaneurol.2021.3671.
MLA (9th ed.) CitationAL, Benedet, et al. "Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum." JAMA Neurology, vol. 78, no. 12, 2021, p. 1471, https://doi.org/10.1001/jamaneurol.2021.3671.